TLDR
- TD Cowen slashed DAL’s price objective from $82 down to $71 due to elevated fuel cost projections
- Research firm indicates airline profit margins face headwinds through 2026 without significant fuel price declines
- Delta’s revenue significantly underperformed expectations — $14.61B actual versus $15.80B forecast
- Company executives offloaded more than 620,000 shares totaling $44M over recent months
- Shares have declined approximately 15% since the start of 2026; average analyst target stands at $79.93
Delta Air Lines is navigating turbulent skies in 2026. Shares declined 2.3% during Monday’s trading session, compounding a year-to-date loss approaching 15%, as investor sentiment sours on the airline’s profitability prospects.
The selling pressure intensified following TD Cowen’s decision to reduce its price objective on DAL from $82 down to $71. The investment firm simultaneously adjusted earnings projections for leading U.S. carriers after incorporating updated fuel price forecasts aligned with present market conditions.
TD Cowen’s research note delivered a stark message: profitability margins across the airline industry face significant headwinds throughout this year absent a substantial decrease in fuel costs. This assessment compounds existing challenges confronting a sector already grappling with widespread cost inflation.
Despite the reduced target, TD Cowen maintained its Buy recommendation on DAL. Even the lowered $71 objective suggests potential upside of approximately 27.7% compared to Monday’s settlement price of $55.61.
DAL finished Monday’s session down $3.40. Trading activity registered around 4.4 million shares, considerably lighter than the typical daily average exceeding 9 million — indicating a measured decline rather than broad-based selling.
Quarterly Results Disappoint Wall Street
Delta’s latest financial report added to investor concerns. The carrier posted fourth-quarter earnings per share of $1.55, narrowly surpassing the consensus estimate of $1.53. However, quarterly revenue reached just $14.61 billion — falling significantly short of the $15.80 billion Wall Street anticipated.
This represents a revenue shortfall exceeding $1 billion, a magnitude that’s difficult to overlook. While sales increased 2.9% compared to the prior-year period, the substantial gap versus projections disappointed market participants.
Executives provided first-quarter 2026 EPS guidance ranging from $0.50 to $0.90, alongside full-year 2026 EPS expectations between $6.50 and $7.50. Current analyst consensus projects $7.63 EPS for fiscal 2026 — positioned near the upper boundary of management’s forecast.
Shares have traded between $34.74 and $76.39 over the past 52 weeks. At the current $55.61 level, DAL remains substantially below its 50-day moving average of $68.99.
Executive Share Sales Draw Attention
Internal trading patterns have sparked interest among market observers. Throughout the most recent quarter, company insiders disposed of 620,550 shares representing approximately $44.1 million in aggregate value. Corporate executives and directors currently maintain just 0.88% ownership of the company.
Notable transactions include: EVP Erik Storey Snell divested 39,420 shares during January at $71.02 per share, reducing his holdings by more than 52%. EVP Steven M. Sear offloaded 38,600 shares in February at $75.05, trimming his position by approximately 27%.
While individual executive sales don’t necessarily signal concern, the concentrated volume across multiple senior leaders within a compressed timeframe warrants consideration.
Regarding institutional ownership, various smaller investment firms initiated new DAL positions throughout Q4 2025. Institutional shareholders collectively control 69.93% of outstanding shares.
The broader Wall Street analyst community maintains a generally positive outlook on DAL. Among 24 analysts tracking the stock, 22 assign a Buy rating, one recommends Strong Buy, and one rates it Hold. The consensus price objective reaches $79.93 — representing substantial upside from present levels.
Additional research firms issuing recent commentary include Wolfe Research ($83 target, Outperform rating), Goldman Sachs ($80, Buy), and Barclays ($85, Overweight).
The equity currently trades at a P/E multiple of 7.25 with a market capitalization approximating $36.3 billion.
